Advanced search
1 file | 671.89 KB Add to list

IκB kinase ε (IKKε): a therapeutic target in inflammation and cancer

Kelly Verhelst (UGent) , Lynn Verstrepen (UGent) , Isabelle Carpentier (UGent) and Rudi Beyaert (UGent)
(2013) BIOCHEMICAL PHARMACOLOGY. 85(7). p.873-880
Author
Organization
Keywords
Inflammation, IKK epsilon, Cancer, NF-kappa B, IRF3, TOLL-LIKE RECEPTOR, TUMOR-SUPPRESSOR CYLD, INTERFERON REGULATORY FACTOR-3, DEPENDENT GENE-TRANSCRIPTION, BREAST-CANCER, INNATE IMMUNITY, RHEUMATOID-ARTHRITIS, ANTIVIRAL RESPONSE, RIG-I, TBK1/IKK-EPSILON KINASES

Downloads

  • (...).pdf
    • full text
    • |
    • UGent only
    • |
    • PDF
    • |
    • 671.89 KB

Citation

Please use this url to cite or link to this publication:

MLA
Verhelst, Kelly, Lynn Verstrepen, Isabelle Carpentier, et al. “IκB Kinase ε (IKKε): a Therapeutic Target in Inflammation and Cancer.” BIOCHEMICAL PHARMACOLOGY 85.7 (2013): 873–880. Print.
APA
Verhelst, K., Verstrepen, L., Carpentier, I., & Beyaert, R. (2013). IκB kinase ε (IKKε): a therapeutic target in inflammation and cancer. BIOCHEMICAL PHARMACOLOGY, 85(7), 873–880.
Chicago author-date
Verhelst, Kelly, Lynn Verstrepen, Isabelle Carpentier, and Rudi Beyaert. 2013. “IκB Kinase ε (IKKε): a Therapeutic Target in Inflammation and Cancer.” Biochemical Pharmacology 85 (7): 873–880.
Chicago author-date (all authors)
Verhelst, Kelly, Lynn Verstrepen, Isabelle Carpentier, and Rudi Beyaert. 2013. “IκB Kinase ε (IKKε): a Therapeutic Target in Inflammation and Cancer.” Biochemical Pharmacology 85 (7): 873–880.
Vancouver
1.
Verhelst K, Verstrepen L, Carpentier I, Beyaert R. IκB kinase ε (IKKε): a therapeutic target in inflammation and cancer. BIOCHEMICAL PHARMACOLOGY. 2013;85(7):873–80.
IEEE
[1]
K. Verhelst, L. Verstrepen, I. Carpentier, and R. Beyaert, “IκB kinase ε (IKKε): a therapeutic target in inflammation and cancer,” BIOCHEMICAL PHARMACOLOGY, vol. 85, no. 7, pp. 873–880, 2013.
@article{3196227,
  author       = {Verhelst, Kelly and Verstrepen, Lynn and Carpentier, Isabelle and Beyaert, Rudi},
  issn         = {0006-2952},
  journal      = {BIOCHEMICAL PHARMACOLOGY},
  keywords     = {Inflammation,IKK epsilon,Cancer,NF-kappa B,IRF3,TOLL-LIKE RECEPTOR,TUMOR-SUPPRESSOR CYLD,INTERFERON REGULATORY FACTOR-3,DEPENDENT GENE-TRANSCRIPTION,BREAST-CANCER,INNATE IMMUNITY,RHEUMATOID-ARTHRITIS,ANTIVIRAL RESPONSE,RIG-I,TBK1/IKK-EPSILON KINASES},
  language     = {eng},
  number       = {7},
  pages        = {873--880},
  title        = {IκB kinase ε (IKKε): a therapeutic target in inflammation and cancer},
  url          = {http://dx.doi.org/10.1016/j.bcp.2013.01.007},
  volume       = {85},
  year         = {2013},
}

Altmetric
View in Altmetric
Web of Science
Times cited: